Zeo ScientifiX Files 8-K
Ticker: ZEOX · Form: 8-K · Filed: Mar 4, 2024 · CIK: 1557376
Sentiment: neutral
Topics: 8-K, corporate-filing, financial-reporting
TL;DR
Zeo ScientifiX filed an 8-K on 3/4/24. Check it out.
AI Summary
Zeo ScientifiX, Inc. filed an 8-K on March 4, 2024, reporting other events and financial statements. The company, formerly known as Organicell Regenerative Medicine, Inc., is incorporated in Nevada and operates in the biological products sector.
Why It Matters
This filing provides an update on Zeo ScientifiX's corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant corporate events or financial updates without immediate, high-impact news.
Key Numbers
- 000-55008 — SEC File Number (Identifies the company's filing with the SEC.)
- 47-4180540 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Zeo ScientifiX, Inc. (company) — Registrant
- Organicell Regenerative Medicine, Inc. (company) — Former company name
- March 4, 2024 (date) — Date of report
- Nevada (jurisdiction) — State of incorporation
FAQ
What specific 'Other Events' are reported in this 8-K filing?
The provided text does not detail the specific 'Other Events' beyond listing it as an item information category.
When was Zeo ScientifiX, Inc. previously known as Organicell Regenerative Medicine, Inc.?
The date of the name change from Organicell Regenerative Medicine, Inc. to Zeo ScientifiX, Inc. was June 25, 2018.
What is Zeo ScientifiX, Inc.'s Standard Industrial Classification (SIC) code?
Zeo ScientifiX, Inc.'s SIC code is 2836, categorized under BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
What is the business address of Zeo ScientifiX, Inc.?
The business address is 3321 College Avenue, Suite 246, Davie, Florida 33314.
What is the fiscal year end for Zeo ScientifiX, Inc.?
The fiscal year end for Zeo ScientifiX, Inc. is October 31.
Filing Stats: 536 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-03-04 17:25:15
Filing Documents
- zeoscientifixinc_8k.htm (8-K) — 29KB
- zeoscientifix_ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 8KB
- 0001829126-24-001316.txt ( ) — 221KB
- ocel-20240304.xsd (EX-101.SCH) — 3KB
- ocel-20240304_lab.xml (EX-101.LAB) — 33KB
- ocel-20240304_pre.xml (EX-101.PRE) — 22KB
- zeoscientifixinc_8k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On March 4, 2024, the Company issued a press release announcing that the Financial Industry Regulatory Authority (" FINRA ") had completed the review and processing of the Company's Issuer Company-Related Action Notification Form, which was submitted to FINRA in connection with the change of our corporate name from " Organicell Regenerative Medicine, Inc. " to " Zeo ScientifiX, Inc. " (which was effective February 20, 2024) and the change in our OTCQB trading symbol from " OCEL " to " ZEOX ," which will be effective with the opening of trading on March 5, 2024. A copy of the press release is attached as Exhibit 99.1 to this Report.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99 .1 Press Release dated March 4, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: March 4, 2024 ZEO SCIENTIFIX, INC. By: /s/ Harry Leider Harry Leider, M.D. Chief Executive Officer 2